NT-proBNP is released in response to increased cardiac wall stress, and its elevation may be more indicative of systemic factors—such as pre-existing heart failure, atrial fibrillation, or other cardiovascular conditions—that contribute to overall mortality risk. The gene discussed is NPPB; the disease is atrial fibrillation.